Newsroom Archives  
   
[04.26.06] Dr. Guizhou Hu, BioSignia, V.P. Research & Development Awarded Triangle Business Journal's Health Care Hero Award in the Category of Innovation
[02.01.06] BioSignia Part of IHPM/Abbott Initiative in China
[10.18.05] BioSignia Scientists Publish Synthesis Analysis Validation Study
[10.21.04] BioSignia’s H-CAT technology named “Best Enabling Tool for Disease Management” by DMAA
[08.16.02] BioSignia Scientist Invited to Present BioMarker Research During International Conference on Drug Development European Federation for Pharmaceutical Sciences Meets December in Basel, Switzerland
[07.26.02] Duke University Medical Center, BioSignia Team Up for Year-Long Study to Test Effectiveness of Intensive “Strategic Health Planning” in Patient Care
[07.02.02] BioSignia Scientists Present Results of Novel Predictive Modeling To Identify New Drug Targets to Prevent Heart Disease
[09.10.01] BioSignia, Inc. Partners With Duke University to Conduct Stroke Study
[06.21.01] BioSignia Presents Diabetes Management Tool at ADA Annual Meeting
[11.10.00] BioSignia® Awarded Two Patents Representing Medical Technology Milestone Unique Tools Help Physicians Predict Chronic Disease Onset, Speed Drugs to Market
[11.01.00] First-of-its-kind technology places power of evidence based medicine at the fingertips of healthcare providers & consumers


 

 

Terms of Use | Privacy Policy | HIPAA Update

BioSignia, Inc. • 401 Harrison Oaks Blvd., Suite 120 • Cary, NC 27513 • (919) 933-2021 • (888) 324-6627
© Copyright 2015 BioSignia, All Rights Reserved